Oct 30, 2025 04:16PM

Oct 30, 2025 04:15PM

Oct 30, 2025 07:01AM

Oct 30, 2025 07:00AM

Oct 29, 2025 07:02AM

Oct 29, 2025 07:00AM

Oct 29, 2025 06:00AM NLS Pharmaceutics announces reverse stock split ahead of Kadimastem merger

Oct 29, 2025 06:00AM

Oct 29, 2025 03:53AM

Oct 27, 2025 07:00AM

Oct 27, 2025 07:00AM

Oct 23, 2025 06:03AM

Oct 23, 2025 06:01AM

Sep 30, 2025 07:01AM NLS Pharmaceutics shareholders approve merger with Kadimastem

Sep 30, 2025 07:00AM

Sep 10, 2025 06:01AM

Sep 10, 2025 06:00AM

Sep 4, 2025 07:39AM

Sep 4, 2025 07:38AM

Jul 17, 2025 07:00AM

Jul 17, 2025 07:00AM NLS Pharmaceutics Highlights Continued Progress in iTOL-102 Diabetes Program as BIRD Foundation Approves Additional Milestone Payment to Kadimastem and iTolerance for Continued Co-Development of Type

Jun 30, 2025 07:00AM

Jun 16, 2025 07:00AM

Apr 15, 2025 09:02AM

Apr 15, 2025 09:00AM

Mar 31, 2025 09:12AM

Mar 31, 2025 09:10AM

Mar 10, 2025 07:04AM NLS Pharmaceutics (NLSP) CEO Issues Letter to Shareholders

Mar 10, 2025 07:00AM

Feb 25, 2025 09:05AM

Feb 10, 2025 07:31AM

Feb 10, 2025 07:30AM

Jan 31, 2025 07:31AM

Jan 31, 2025 07:30AM

Jan 28, 2025 07:32AM NLS Pharmaceutics (NLSP) Launches a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

Jan 28, 2025 07:30AM

Jan 16, 2025 09:32AM

Jan 8, 2025 07:42AM

Dec 30, 2024 07:31AM

Dec 30, 2024 07:30AM

Dec 19, 2024 07:31AM

Dec 19, 2024 07:30AM NLS Pharmaceutics and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance, Inc. for an FDA Pre-IND Meeting for an Innovative Breakthrough Type 1 Diabetes Treatment

Dec 11, 2024 07:32AM

Dec 11, 2024 07:30AM

Nov 18, 2024 07:30AM

Nov 4, 2024 07:03AM

Nov 4, 2024 07:00AM

Jul 29, 2024 07:02AM

Jul 29, 2024 07:00AM NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge

Mar 20, 2024 07:34AM

1,155,254 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All